Sanofi SA - Strategy, SWOT and Corporate Finance Report

Sanofi SA - Strategy, SWOT and Corporate Finance Report

  • Products Id :- 518CE898-AD33-42BF-8668-486ECA8F3D59
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Sanofi SA-Strategy, SWOT and Corporate Finance Report


Sanofi SA-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Sanofi SA (Sanofi or 'the group') is a France-based international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. In addition, it provides prescription products, consumer healthcare products, generics, and vaccines. It offers products related to Vaccines that include pediatric vaccines for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (Hib), influenza vaccines and adult and adolescent booster vaccines. The group operates across North America and Europe. Sanofi is headquartered in Paris, France.


- Detailed information on Sanofi SA required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis

- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments

- Intelligence on Sanofi SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Sanofi SA, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi SA and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sanofi SA as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sanofi SA's business structure, strategy and prospects.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Company Snapshot 2

Table of Contents 5

Sanofi SA: Company Overview 9

Sanofi SA: Overview and Key Facts 9

Sanofi SA: Overview 9

Sanofi SA: Key Facts 9

Sanofi SA: Key Employees 11

Sanofi SA: Key Employee Biographies 13

Sanofi SA: Major Products and Services 14

Sanofi SA: Company History 15

Sanofi SA: Management Statement 27

Sanofi SA: Locations and Subsidiaries 29

Sanofi SA: Key Competitors 30

Sanofi SA: Company Analysis 31

Sanofi SA: Business Description 31

Sanofi SA: SWOT Analysis 33

Sanofi SA: SWOT Overview 33

Sanofi SA: Strengths 33

Sanofi SA: Weaknesses 34

Sanofi SA: Opportunities 34

Sanofi SA: Threats 34

Sanofi SA: Corporate Financial Deals Activity 37

Sanofi SA: Financial Deals Overview 37

Sanofi SA: Targets and Partners 39

Sanofi SA: Top Deals 2014-2018YTD 42

Sanofi SA: Advisors 43

Sanofi SA: Top Legal Advisors 43

Sanofi SA: Top Financial Advisors 43

Sanofi SA: Mergers and Acquisitions 45

Sanofi SA: Corporate Venturing 46

Sanofi SA: Capital Raising 47

Sanofi SA: Partnership 48

Sanofi SA: Divestments 49

Sanofi SA: Recent Developments 50

Sanofi SA: News and Events Summary 50

Sanofi SA: Business Expansion 54

Sanofi SA: Contracts 55

Sanofi SA: Corporate Governance 56

Sanofi SA: Financial Deals 57

Sanofi SA: Regulatory and Legal Events 57

Sanofi SA: Strategy and Operations 58

Appendix 59

Contact Us 59

Methodology 59

About MarketLine 60

List of Figures

Figure 1: Sanofi SA: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Sanofi SA: M&A Activity by Geography (TTM )

Figure 3: Sanofi SA: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 4: Sanofi SA: M&A Average Deal Size-Value (USD m)

Figure 5: Sanofi SA: M&A Volume and Value Trend (2014-YTD 2018)

Figure 6: Sanofi SA: M&A Activity

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

select a license
Single User License
USD 175 INR 12493
Site License
USD 350 INR 24987
Corporate User License
USD 525 INR 37480



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]